Frontlight ResearchEarly access
Trial site
Los Angeles Cancer Network (LACN)
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Head and neck cancer1 trial
- Lung cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 32 trials
- Phase 2/31 trial
- Status
- Recruiting3 trials
- Lead sponsor
- Daiichi Sankyo1 trial
- Inhibrx Biosciences, Inc1 trial
- Pfizer1 trial
Running trials
Recruiting
Recruiting
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Prostate cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026